慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)作为临床呼吸系统常见疾病之一,具有高患病率和高死亡率的特点,严重影响着慢性阻塞性肺疾病患者的生活质量,并给社会、家庭带来较大的经济和心理负担。常规西医治疗本病...慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)作为临床呼吸系统常见疾病之一,具有高患病率和高死亡率的特点,严重影响着慢性阻塞性肺疾病患者的生活质量,并给社会、家庭带来较大的经济和心理负担。常规西医治疗本病主要以积极对症治疗为主,而中医药对治疗慢性阻塞性肺疾病往往具有较好的临床疗效。本文通过分析近年来大量相关文献和临床研究,并结合中医药在临床辨治慢性阻塞性肺疾病的实际疗效,得出“从痰瘀论治慢性阻塞性肺疾病的临床效果较佳”,故以“痰瘀互结”理论为角度,从痰瘀型慢性阻塞性肺疾病的理论依据、临床治疗出发作出综述,为中医药临床从痰瘀治疗该病提供理论依据。Chronic Obstructive Pulmonary Disease (COPD), as one of the common diseases of clinical respiratory system, has the characteristics of the high morbidity and high mortality rate, which seriously affects the quality of life of patients with chronic obstructive pulmonary disease and brings a larger economic and psychological burden on society and family. Conventional Western medicine mainly focuses on the positive symptomatic treatment of this disease, while traditional Chinese medicine often has better clinical efficacy in the treatment of chronic obstructive pulmonary disease. Through analyzing a large number of relevant literature and clinical studies in recent years and combining with the actual therapeutic effect of traditional Chinese medicine in the clinical differentiation of chronic obstructive pulmonary disease, this paper concludes that “the clinical effect of treating chronic obstructive pulmonary disease from phlegm and blood stasis is better”. Therefore, based on the theory of “interjunction of phlegm and blood stasis”, this paper summarizes the theoretical basis and clinical treatment of chronic obstructive pulmonary disease with phlegm and blood stasis, providing a theoretical basis for TCM clinical treatment of this disease from phlegm and blood stasis.展开更多
血管性痴呆(Vascular dementia, VD)作为临床常见的一种严重认知障碍综合征,常表现为记忆、执行等高级认知功能的严重受损。目前,血管性痴呆的患病人群逐年增加,严重影响患者的生存质量,给家庭及社会带来较大的经济和精神负担。常规西...血管性痴呆(Vascular dementia, VD)作为临床常见的一种严重认知障碍综合征,常表现为记忆、执行等高级认知功能的严重受损。目前,血管性痴呆的患病人群逐年增加,严重影响患者的生存质量,给家庭及社会带来较大的经济和精神负担。常规西医治疗本病以对症、控制脑血管疾病或脑血管危险因素治疗为主,临床效果欠佳。而中医药在临床治疗该病常具有良好的临床疗效,可以延缓该病的进展。本文通过大量分析相关文献、临床观察并结合临床实际疗效,得出“肝郁血瘀”是血管性痴呆的核心病机,故本文以“肝郁血瘀”为角度,从发病机制、临床治疗作出综述,为中医药从“肝郁血瘀”治疗该病提供理论依据。As a common clinical syndrome of severe cognitive impairment, Vascular dementia (VD) is often manifested by severe impairment of higher cognitive functions such as memory and executive function. At present, the number of people with vascular dementia is increasing year by year, which seriously affects the quality of life of patients and brings greater economic and spiritual burden to the family and society. Conventional Western medicine treatment of this disease is mainly to treat the symptoms, control cerebrovascular diseases or cerebrovascular risk factors, and the clinical effect is not good. Traditional Chinese medicine in clinical treatment of the disease often has a good clinical effect and can delay the progression of the disease. Based on a large number of relevant literature analysis, clinical observation and clinical effect, this paper concludes that “liver-stagnation and blood stasis” is the core pathogenesis of vascular dementia. Therefore, this paper reviews the pathogenesis and clinical treatment of “liver-stagnation and blood stasis” from the perspective of “liver-stagnation and blood stasis”, providing a theoretical basis for the treatment of this disease by traditional Chinese medicine.展开更多
败毒散又名人参败毒散、羌活汤、十味汤、人参前胡散,最早记载于宋代《太平惠民和剂局方》卷二,吴昆所著《医方考》云:“培其正气,败其毒邪,故曰败毒”,临床上曾广泛应用于治疗疫病。后世医家基于中医辨证及相关研究,将该方剂运用于其...败毒散又名人参败毒散、羌活汤、十味汤、人参前胡散,最早记载于宋代《太平惠民和剂局方》卷二,吴昆所著《医方考》云:“培其正气,败其毒邪,故曰败毒”,临床上曾广泛应用于治疗疫病。后世医家基于中医辨证及相关研究,将该方剂运用于其他呼吸系统疾病的治疗亦取得较好的临床疗效。通过查阅、分析、整理相关文献,综述败毒散的组方用药、药理学研究、分子机制研究,以及在呼吸系统疾病中的临床应用,旨在为败毒散的临床应用和后续深入研究提供参考。Baidu San, also known as Renshen Baidu San, Qianghuo Tang, Shiwei Tang, and Renshen Qianhu San, was first recorded in Volume II of Song Dynasty’s “Taiping Huimin Heji Jufang” (Bureau of Medical Administration for the Benefit of the People). Wu Kun’s “Yi Fang Kao” (Examination of Medical Formulas) states: “It cultivates the body’s vital qi and eliminates pathogenic toxins, hence the name ‘Baidu’ (eliminating toxins).” This formula is widely used clinically in the treatment of influenza. Based on traditional Chinese medicine syndrome differentiation and modern pharmacological research, later generations of doctors have applied this formula to the treatment of respiratory diseases and achieved good clinical results. Through reviewing, analyzing, and organizing relevant literature, this article summarizes the composition, pharmacological research, molecular mechanism research, and clinical application of Baidu San in respiratory diseases, aiming to provide references for the clinical application and subsequent in-depth research of Baidu San.展开更多
文摘慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)作为临床呼吸系统常见疾病之一,具有高患病率和高死亡率的特点,严重影响着慢性阻塞性肺疾病患者的生活质量,并给社会、家庭带来较大的经济和心理负担。常规西医治疗本病主要以积极对症治疗为主,而中医药对治疗慢性阻塞性肺疾病往往具有较好的临床疗效。本文通过分析近年来大量相关文献和临床研究,并结合中医药在临床辨治慢性阻塞性肺疾病的实际疗效,得出“从痰瘀论治慢性阻塞性肺疾病的临床效果较佳”,故以“痰瘀互结”理论为角度,从痰瘀型慢性阻塞性肺疾病的理论依据、临床治疗出发作出综述,为中医药临床从痰瘀治疗该病提供理论依据。Chronic Obstructive Pulmonary Disease (COPD), as one of the common diseases of clinical respiratory system, has the characteristics of the high morbidity and high mortality rate, which seriously affects the quality of life of patients with chronic obstructive pulmonary disease and brings a larger economic and psychological burden on society and family. Conventional Western medicine mainly focuses on the positive symptomatic treatment of this disease, while traditional Chinese medicine often has better clinical efficacy in the treatment of chronic obstructive pulmonary disease. Through analyzing a large number of relevant literature and clinical studies in recent years and combining with the actual therapeutic effect of traditional Chinese medicine in the clinical differentiation of chronic obstructive pulmonary disease, this paper concludes that “the clinical effect of treating chronic obstructive pulmonary disease from phlegm and blood stasis is better”. Therefore, based on the theory of “interjunction of phlegm and blood stasis”, this paper summarizes the theoretical basis and clinical treatment of chronic obstructive pulmonary disease with phlegm and blood stasis, providing a theoretical basis for TCM clinical treatment of this disease from phlegm and blood stasis.
文摘血管性痴呆(Vascular dementia, VD)作为临床常见的一种严重认知障碍综合征,常表现为记忆、执行等高级认知功能的严重受损。目前,血管性痴呆的患病人群逐年增加,严重影响患者的生存质量,给家庭及社会带来较大的经济和精神负担。常规西医治疗本病以对症、控制脑血管疾病或脑血管危险因素治疗为主,临床效果欠佳。而中医药在临床治疗该病常具有良好的临床疗效,可以延缓该病的进展。本文通过大量分析相关文献、临床观察并结合临床实际疗效,得出“肝郁血瘀”是血管性痴呆的核心病机,故本文以“肝郁血瘀”为角度,从发病机制、临床治疗作出综述,为中医药从“肝郁血瘀”治疗该病提供理论依据。As a common clinical syndrome of severe cognitive impairment, Vascular dementia (VD) is often manifested by severe impairment of higher cognitive functions such as memory and executive function. At present, the number of people with vascular dementia is increasing year by year, which seriously affects the quality of life of patients and brings greater economic and spiritual burden to the family and society. Conventional Western medicine treatment of this disease is mainly to treat the symptoms, control cerebrovascular diseases or cerebrovascular risk factors, and the clinical effect is not good. Traditional Chinese medicine in clinical treatment of the disease often has a good clinical effect and can delay the progression of the disease. Based on a large number of relevant literature analysis, clinical observation and clinical effect, this paper concludes that “liver-stagnation and blood stasis” is the core pathogenesis of vascular dementia. Therefore, this paper reviews the pathogenesis and clinical treatment of “liver-stagnation and blood stasis” from the perspective of “liver-stagnation and blood stasis”, providing a theoretical basis for the treatment of this disease by traditional Chinese medicine.
文摘败毒散又名人参败毒散、羌活汤、十味汤、人参前胡散,最早记载于宋代《太平惠民和剂局方》卷二,吴昆所著《医方考》云:“培其正气,败其毒邪,故曰败毒”,临床上曾广泛应用于治疗疫病。后世医家基于中医辨证及相关研究,将该方剂运用于其他呼吸系统疾病的治疗亦取得较好的临床疗效。通过查阅、分析、整理相关文献,综述败毒散的组方用药、药理学研究、分子机制研究,以及在呼吸系统疾病中的临床应用,旨在为败毒散的临床应用和后续深入研究提供参考。Baidu San, also known as Renshen Baidu San, Qianghuo Tang, Shiwei Tang, and Renshen Qianhu San, was first recorded in Volume II of Song Dynasty’s “Taiping Huimin Heji Jufang” (Bureau of Medical Administration for the Benefit of the People). Wu Kun’s “Yi Fang Kao” (Examination of Medical Formulas) states: “It cultivates the body’s vital qi and eliminates pathogenic toxins, hence the name ‘Baidu’ (eliminating toxins).” This formula is widely used clinically in the treatment of influenza. Based on traditional Chinese medicine syndrome differentiation and modern pharmacological research, later generations of doctors have applied this formula to the treatment of respiratory diseases and achieved good clinical results. Through reviewing, analyzing, and organizing relevant literature, this article summarizes the composition, pharmacological research, molecular mechanism research, and clinical application of Baidu San in respiratory diseases, aiming to provide references for the clinical application and subsequent in-depth research of Baidu San.
